In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8

Leukemia Research

Volumn 29, Issue 2, 2005, Pages 185-196

  Ryningen, Anita ^a   Wergeland, Line ^b   Glenjen, Nils ^a   Gjertsen, Bjørn Tore ^a   Bruserud, Øystein ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acute myelogenous leukemia; Apoptosis; Fibroblasts; Interleukin 8; Proliferation

Indexed keywords

CYTOKINE; INTERLEUKIN 8;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; APOPTOSIS; ARTICLE; BLAST TRANSFORMATION; BONE MARROW CELL; CELL INTERACTION; CELL PROLIFERATION; CELL SEPARATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; COCULTURE TECHNIQUES; CYTOKINES; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-8; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; STROMAL CELLS;

EID: 10644243397     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2004.06.008     Document Type: Article

References (31)

1. B. Löwenberg, J.R. Downing, and A. Burnett Acute myeloid leukemia N Engl J Med. 341 1999 1051 1062
2. K. Wheatley, A.K. Burnett, and A.H. Goldstone A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukemia derived from the MRC AML 10 trial Br. J. Haematol. 107 1999 69 79
3. K. Mrozek, K. Heinonen, A. de la Chapelle, and C.D. Bloomfield Clinical significance of cytogenetics in acute myeloid leukemia Semin. Oncol. 24 1997 17 31
4. P.D. Kottaridis, R.E. Gale, and M.E. Frew The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 Blood 98 2001 1752 1759
5. S.P. Whitman, K.J. Archer, and L. Feng Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and internal tandem duplication of FLT3: a cancer and leukemia group B study Cancer Res. 61 2001 7233 7239
6. C. Thiede, C. Steudel, and B. Mohr Analysis of Flt3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis Blood 99 2002 4326 4335
7. T. Padro, S. Ruiz, and R. Bieker Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia Blood 95 2000 2637 2644
8. A. Aguayo, E. Estey, and H. Kantarjian Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 94 1999 3717 3721
9. A. Aguayo, H.M. Kantarjian, and E.H. Estey Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes Cancer 95 2002 1923 1930
10. R. Lai, E. Estey, and Y. Shen Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome Cancer 94 2002 14 17
11. B. Torok-Storb, M. Iwata, L. Graf, J. Gianotti, H. Horton, and M.C. Byrne Dissecting the marrow microenvironment Ann NY Acad. Sci. 872 1999 164 170
12. F. Rougier, F. Dupuis, and Y. Denizot Human bone marrow fibroblasts - an overview of their characterization, proliferation and inflammatory mediator production Hematol Cell Ther. 38 1996 241 246
13. P. Bianco, M. Riminucci, S. Gronthos, and P.G. Robey Bone marrow stromal stem cells: nature, biology and potential applications Stem Cells 19 2001 180 192
14. S.M. Garrido, F.R. Appelbaum, C.L. Willman, and D.E. Banker Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5) Exp Hematol. 29 2001 448 457
15. Ø. Bruserud Effects of dipyridamole, theophyllamine and verapamil on spontaneous proliferation of myelogenous leukemia cells Acta Oncol. 31 1992 53 58
16. Ø. Bruserud, B.T. Gjertsen, and O.T. Brustugun Effect of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia Leukemia 9 1995 1910 1920
17. Ø. Bruserud, B.T. Gjertsen, and H.L. von Volkman In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines J Hematother Stem Cell Res. 9 2000 923 932
18. Ø. Bruserud, T.S. Huang, N. Glenjen, B.T. Gjertsen, and B. Foss Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemic blasts Haematologia 87 2002 584 595
19. Ø. Bruserud, N.I. Glenjen, A. Ryningen, and E. Ulvestad In vitro culture of human acute myelogenous leukemia (ALL) cells in serum-free media: a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines Leukemia Res. 27 2002 455 464
20. I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early cells using fluorescein labelled Annexin V J Immunol Methods 184 1995 39 51
21. E. Sitnicka, Q.R. Wang, S. Tsai, and N.S. Wolf Support versus inhibition of hematopoiesis by two characterized stromal cell types. Stem cells 13 6 1995 655 665
22. M.A. Lichtman Interrupting the inhibition of normal hematopoiesis in myelogenous leukemia: a hypothetical approach to therapy Stem Cells 18 2000 304 306
23. Ø. Bruserud, B.T. Gjertsen, B. Foss, and T.-s. Huang New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of AML cells - the present use in experimental studies and the possible importance for future therapeutic strategies Stem Cells 19 2001 1 11
24. D. Motorin, A. Bakken, J. Foss Abrahamsen, P. Ernst, and O. Bruserud Characterization of clonogenic progenitors in autologous peripheral blood stem cell grafts: evaluation of a simple in vitro assay suitable for routine clinical use Hematology 8 5 2003 313 318
25. A.M. Bakken, O. Bruserud, and J.F. Abrahamsen No differences in colony formation of peripheral blood stem cells frozen with 5 or 10% dimethyl sulfoxide J Hematother Stem Cell Res. 12 3 2003 351 358
26. O. Bruserud, A. Ryningen, L. Wergeland, N.I. Glenjen, and B.T. Gjertsen Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts Haematologica 89 4 2004 391 402
27. O. Bruserud, N. Glenjen, B.T. Gjertsen, L. Herfindal, and S.O. Doskeland Use of marine toxins in combination with cytotoxic drugs for induction of apoptosis in acute myelogenous leukaemia cells Expert Opin Biol Ther. 2 2002 197 210
28. N. Glenjen, R. Hovland, L. Wergeland, Ø. Wendelbo, P. Ernst, and Ø. Bruserud The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status Eur J Haematol. 71 2003 163 173
29. F. Vinante, A. Rigo, C. Vincenzi, M.M. Ricetti, R. Marrocchella, M. Chilosi, M.A. Cassatella, L. Bonazzi, and G. Pizzolo IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells Leukemia 7 10 1993 1552 1556
30. E.S. de Bont, E. Vellenga, G. Molema, E. van Wering, L.F. de Leij, and W.A. Kamps A possible role for spontaneous interleukin-8 production by acute myeloid leukemic cells in angiogenesis related processes: work in progress Med Pediatr Oncol. 37 6 2001 511 517
31. Ø. Bruserud, R. Hovland, L. Wergeland, T-s. Huang, and B.T. Gjertsen Flt3-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of the effects of Flt3-ligand in AML cell populations with and without Flt3 abnormalities Haematologica 88 2003 416 428